Brief: Nautilus Biotechnology Announces Agreement With The Allen Institute, Further Validating Its Approach To Single-Molecule Proteomics
30/07/2025 13:48
July 30 (Reuters) - Nautilus Biotechnology Inc NAUT.O: NAUTILUS BIOTECHNOLOGY ANNOUNCES AGREEMENT WITH THE ALLEN INSTITUTE, FURTHER VALIDATING ITS APPROACH TO SINGLE-MOLECULE PROTEOMICS Source text: ID:nGNX7ZLjKl Further company coverage: NAUT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nautilus Biotechnology
See all newsNautilus Biotechnology, Inc. expected to post a loss of 14 cents a share - Earnings Preview
Brief: Nautilus Biotechnology May Offer Up To $300 Million Of Securities - SEC Filing
Nautilus Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Nautilus Biotechnology posts first revenue, Q2 net loss narrows
Brief: Nautilus Biotechnology Q2 EPS USD -0.11